Abstract:The incidence of colonic inflammatory bowel disease (IBD) is increasing globally, with prevalence rates of approximately 1 in 200 adults in the highest-risk populations [1]. One of the consequences of longstanding colonic inflammation is the potential development of premalignant lesions and colorectal cancer (CRC). Although the risk of CRC in IBD is declining, the cumulative risk is estimated to be 1%, 2%, and 5% after 10, 20, and >20 years of disease, respectively [2]. "We should be optimistic that with improved assessment and resection techniques, high rates of en bloc, safe, and complete resection will be achieved in IBD, resulting in the very low recurrence rates seen in the non-IBD population." Therefore, patients with IBD are usually invited to undergo screening colonoscopies 8 years after symptom onset, followed by surveillance procedures depending on patient-specific risk factors. The aim of any screening and surveillance program is to reduce morbidity and mortality due to the disease. With improvements in colonoscopy, most IBD dysplasia can be detected and removed, meaning that the prevention of CRC is possible. To improve prevention, complete endoscopic resection of the dysplastic lesions is important. The challenges associated with IBD dysplasia are that these lesions are often flat, without clear and discrete borders, and can be within inflamed areas of the colon. Inflammation can lead to fibrosis and tethering, limiting endoscopic resection. In this issue of Endoscopy , Angajala et al. [3] explore the challenges associated with endoscopic resection of laterally spreading IBD-associated dysplastic lesions. The authors compared outcomes between IBD- and non-IBD-associated lesions at a tertiary referral center between 2015 and 2021. The majority of the procedures were performed by "expert endoscopists" with dedicated training in endoscopic colonic resection. A total of 210 lesions were included (187 non-IBD and 23 IBD). The average size of the lesions was "large" at 25 mm in the IBD group and 20 mm in the non-IBD group. Most lesions were tubular adenomas with low grade dysplasia or sessile serrated lesions (91% in both cohorts). The morphology of the lesions was similar, and they were also distributed similarly throughout the colon. Despite comparable baseline characteristics, the primary outcome of the study reported significantly higher recurrence rates in the IBD cohort (30%) than in the controls (21%). The recurrence rates in this tertiary center were high in both groups, which is a notable finding. While most recurrences can usually be dealt with endoscopically, this can be more challenging with laterally spreading lesions, and current or prior inflammation can hamper the complete removal of recurrent tissue. With techniques such as excision of a 2–3-mm margin of normal tissue and thermal ablation of defect margins following endoscopic mucosal resection, much lower rates of recurrence are possible. In recent non-IBD cohorts, rates as low as 2% have been reported [4]. Whether these results can be achieved in IBD remains uncertain and it would be interesting to observe whether a significant difference in recurrence persists in contemporary cohorts. The rates of en bloc resection were significantly lower in the IBD cohort (9% vs. 57%), but the difference in recurrence was maintained after adjustment, bearing in mind the small sample size. There are several reasons why en bloc endoscopic mucosal resection may be more challenging in patients with IBD. These lesions can be more difficult to inspect in areas of the colon with active or prior inflammation and scarring, and submucosal injection can be complicated by inflammation and fibrosis. Endoscopic submucosal dissection (ESD) is an obvious candidate technique for improving the rate of en bloc resection. Although ESD is technically challenging and time consuming, the efficacy of the technique is supported in the literature, with an en bloc resection rate of 100% and R0 rate of 96% achieved in a recent IBD cohort [5]. The increased risk with ESD is important to consider, with perforation and bleeding rates being 6% and 8%, respectively. Complications from ESD could be higher in a delicate IBD colon, but most can be managed endoscopically [6]. The additional benefit of achieving R0 resection is that there is a reduced need for "site-check" procedures and surveillance, which is important as the IBD cohort can be subjected to numerous endoscopies, particularly those with dysplastic lesions who undergo more intense surveillance. There will be a rise in the overall number of IBD dysplastic lesions due to the increasing incidence of IBD, longer survival, and increased use of colonoscopy. However, it is important to remember that the overall scale of this problem is relatively small. This is reflected in the small number of patients with IBD included in this (n = 14) and ot -Abstract Truncated-

Image-enhanced endoscopy is critical in the surveillance of patients with colonic IBD

Image enhanced colonoscopy: updates and prospects-a review

From random to precise: updated colon cancer screening and surveillance for inflammatory bowel disease

Evaluation and Detection of Dysplasia in IBD: the Role of Chromoendoscopy and Enhanced Imaging Techniques

A Systematic Review and Meta-Analysis of Endoscopic Surveillance Studies for Detecting Dysplasia in Patients With Inflammatory Bowel Disease

Advanced Endoscopic Imaging Techniques for the Study of Colonic Mucosa in Patients with Inflammatory Bowel Disease

Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy

N32 Implementation of chromoendoscopy in colorectal cancer screening in patients with Inflammatory Bowel Disease

An Update on Surveillance in Ulcerative Colitis

What Is the Risk? Epidemiology and Evidence for Surveillance Regimens

Detecting colorectal lesions with image-enhanced endoscopy: an updated review from clinical trials

Endoscopic approaches to the management of dysplasia in inflammatory bowel disease: A state-of-the-art narrative review

High-definition chromoendoscopy results in more significant dysplasia detection than white light endoscopy with random biopsies in ulcerative colitis patients: A single-center retrospective study

Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives

Surveillance strategies for colitis-associated cancer: state of the art and future perspectives

Application of image-enhanced endoscopy in diagnosis of colorectal cancer

Can we improve the endoscopic resection of dysplastic lesions in colonic inflammatory bowel diseases?

Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis

Image-enhanced endoscopy technology in the gastrointestinal tract: What is available?

Cancer Biology or Ineffective Surveillance? A Multicentre Retrospective Analysis of Colitis-Associated Post-Colonoscopy Colorectal Cancers